Abstract: A hand sanitizing kit that includes: at least one single-dose hand sanitizer packet dispensing station component and at least one multiple-dose hand sanitizer dispensing station component. The single-dose hand sanitizer packet dispensing station contains a plurality of single-dose hand sanitizer packets and is adapted to dispense these single-dose hand sanitizer packets. The dispensing station components may include one or more mounts for releasably secure placement or for secure placement of the dispensing station component. The multiple-dose hand sanitizer dispensing station component is a desirably a hand sanitizer pump dispenser. The kit may include instructions or information about positions in a medical setting to locate the single-dose hand sanitizer packet dispensing station component or multiple-dose hand sanitizer dispensing station component to provide accessible hand sanitizing.

Abstract: Cleansing wipes comprising a film forming polymeric material and a cleansing agent stored in dry form are disclosed. The cleansing wipes are water disintegratable such that upon contact with water, the cleansing wipes release the cleansing agent and begin to dissolve/disperse into the water. Full dissolution/dispersion of the cleansing wipes occurs in about 60 seconds or less after contact with water to allow for a sufficient time for cleansing of the hands or other skin area.

Abstract: Methods for neutralizing dust mite feces are disclosed. In one embodiment, a botanical extract having a BAPNA-Trypsin Inhibition (IC50×10?3 (%, v/v or w/v) of from about 0.01 to about 500 and a sufficient solubility in water is introduced into water to form an aqueous botanical extract solution. The aqueous botanical extract solution is atomized into an area being treated such that the botanical extract contacts and neutralizes the dust mite feces located in the area. Particularly preferred botanical extracts for use in the botanical extract aqueous solutions of the present invention include Green Tea Extra and Grape Seed Extract.

Abstract: Methods for neutralizing dust mite feces are disclosed. In one embodiment, a botanical extract having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v) of from about 0.01 to about 500 and a sufficient solubility in water is introduced into water to form an aqueous botanical extract solution. The aqueous botanical extract solution is atomized into an area being treated such that the botanical extract contacts and neutralizes the dust mite feces located in the area. Particularly preferred botanical extracts for use in the botanical extract aqueous solutions of the present invention include Green Tea Extra and Grape Seed Extract.

Abstract: Disclosed are methods products such as wet wipes and absorbents capable of providing a skin health benefit when utilized in the intended fashion. More specifically, the products described herein comprise an antioxidant agent, such as a botanical extract, which is capable of reducing the amount of oxidation on the skin's surface resulting in improved skin health. The antioxidant agent has an antioxidant potential at three minutes of at least about 25% as determined by a AST Antioxidant Status Test set forth herein. In another embodiment, the antioxidant agent has an antioxidant potential at thirty minutes of at least about 20% as determined by a AST Antioxidant Status Test set forth herein.

Abstract: Novel wound management products are disclosed. The products incorporate an increased amount of cationic compounds in the fibrous matrix of the substrate which allow the product to bind and remove various microbes from the surface of a wound. The products disclosed herein do not necessarily kill microbes on the wound's surface, but dislodge and bind the microbe through electrostatic interactions between the product and the microbe and allow the microbe to be removed by a positively charged substrate.

Abstract: Methods of making and using, as prophylactics or therapeutics for preventing or treating certain diseases including cancer, O-desulfated heparin compositions, preferably 2-O, 3-O desulfated heparin compositions, wherein the methods permit regulating the degree of 2-O, 3-O desulfation to produce compositions that are variably desulfated upto about 99% and 75% desulfated at the 2-O and 3-O positions, respectively.

Abstract: A novel class of highly sulfated maltooligosaccharide having heparin-like activity is described, as well as methods for using these oligosaccharides to treat certain diseases including cancer, and retinopathies.

Abstract: Methods of making and using, as prophylatics or therapeutics for preventing or treating certain diseases including cancer, O-desulfated heparin compositions, preferably 2-O, 3-O desulfated heparin compositions, wherein the methods permit regulating the degree of 2-O, 3-O desulfation to produce compositions that are variably desulfated including about 99% and 75% desulfated at the 2-O and 3-O positions, respectively.